[1]刘 强,何 丽,李素芳,等.单核细胞/高密度脂蛋白胆固醇比值、成纤维细胞生长因子21、C肽表达水平与2型糖尿病性骨质疏松症相关性分析[J].陕西医学杂志,2024,(1):109-112,117.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.024]
　LIU Qiang,HE Li,LI Sufang,et al.Correlation between the expression levels of MHR,FGF21,C peptide and type 2 diabetic osteoporosis[J].,2024,(1):109-112,117.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.024]
点击复制

单核细胞/高密度脂蛋白胆固醇比值、成纤维细胞生长因子21、C肽表达水平与2型糖尿病性骨质疏松症相关性分析
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年1期
页码:
109-112,117
栏目:
临床检验
出版日期:
2024-01-31

文章信息/Info

Title:
Correlation between the expression levels of MHR,FGF21,C peptide and type 2 diabetic osteoporosis
作者:
刘 强1; 何 丽1; 李素芳1; 苟 伟2
(1.成都医学院附属肿瘤医院 成都市第七人民医院内分泌科,四川 成都 610213; 2.成都医学院附属肿瘤医院 成都市第七人民医院神经内科,四川 成都 610213)
Author(s):
LIU Qiang; HE Li; LI Sufang; GOU Wei
(Department of Endocrine,Affiliated Tumor Hospital of Chengdu Medical College,Chengdu 610213,China)
关键词:
单核细胞/高密度脂蛋白胆固醇比值;  成纤维细胞生长因子21;  C肽;  2型糖尿病;  骨质疏松
Keywords:
Monocyte/HDL-C ratio;  Fibroblast growth factor 21;  C peptide;  Type 2 diabetes mellitus;  Osteoporosis
分类号:
R 587.2
DOI:
DOI:10.3969/j.issn.1000-7377.2024.01.024
文献标志码:
A
摘要:
目的:分析单核细胞/高密度脂蛋白胆固醇比值(MHR)、成纤维细胞生长因子21(FGF21)、C肽表达水平与2型糖尿病(T2DM)性骨质疏松症患者的相关性。方法:选取收治的T2DM性骨质疏松症患者90例为研究组,选取同期治疗的单纯T2DM患者57例为对照组。比较两组一般资料、骨钙素(BGP)、25羟基维生素D3[25(OH)D3]、Ⅰ型前胶原N端前肽(PINP)、MHR、FGF21、C肽水平差异; 采用Spearman秩相关分析MHR、FGF21、C肽与患者骨代谢指标[BGP、25(OH)D3、PINP]的相关性; 多元Logistic回归分析影响T2DM患者发生骨质疏松症的危险因素; 绘制ROC曲线评价MHR、FGF21、C肽及三者联合检测对T2DM患者发生骨质疏松症的诊断价值。结果:研究组女性占比率高于对照组(P<0.05); 相较于对照组,研究组MHR水平更高,而BGP、25(OH)D3、PINP、FGF21及C肽水平更低(均P<0.05); Spearman相关性分析显示,MHR与BGP、25(OH)D3、PINP均呈负相关(均P<0.05),FGF21及C肽与BGP、25(OH)D3、PINP均呈正相关(均P<0.05); 多元Logistc分析显示,MHR是T2DM患者发生骨质疏松症的危险因素(P<0.05); FGF21及C肽是T2DM患者发生骨质疏松症的保护因素(均P<0.05); ROC曲线显示,MHR、FGF21、C肽及三者联合检测预测T2DM患者发生骨质疏松的曲线下面积分别为0.894、0.759、0.810、0.969。结论: T2DM骨质疏松症患者MHR水平上升,FGF21、C肽水平下降,且上述指标与患者骨质疏松密切相关,通过联合检测MHR、FGF21、C肽三者水平对于预测T2DM患者发生骨质疏松具有较好的应用价值。
Abstract:
Objective:To analyze the correlation between monocyte/high-density lipoprotein cholesterol ratio(MHR),fibroblast growth factor 21(FGF21),C-peptide expression levels and osteoporosis in patients with type 2 diabetes mellitus(T2DM).Methods:A total of 90 patients with T2DM osteoporosis were selected as the study group,and 57 patients with simple T2DM treated in the hospital during the same period were selected as the reference group.The general data,osteocalcin(BGP),25-hydroxyvitamin D3[25(OH)D3],N-terminal propeptide of type Ⅰ procollagen(PINP),MHR,FGF21 and C-peptide levels were compared between the two groups.Spearman rank correlation was used to analyze the correlation between MHR,FGF21,C-peptide and BGP,25(OH)D3,PINP.Multivariate Logistic regression analysis was used to analyze the risk factors of osteoporosis in T2DM patients.ROC curve was drawn to evaluate the diagnostic value of MHR,FGF21,C-peptide and their combined detection for osteoporosis in patients with T2DM.Results:The proportion of women in the study group was higher than that in the reference group(P<0.05).The level of MHR in the study group was higher than that in the reference group,and the levels of BGP,25(OH)D3,PINP,FGF21 and C-peptide were lower than those in the reference group(all P<0.05).Spearman correlation analysis showed that MHR was negatively correlated with BGP,25(OH)D3 and PINP,while FGF21 and C-peptide were positively correlated with BGP,25(OH)D3 and PINP(all P<0.05).Multivariate Logistic regression analysis showed that MHR was a risk factor for osteoporosis in T2DM patients,and FGF21 and C-peptide were protective factors for osteoporosis in T2DM patients(all P<0.05).The results of ROC curve showed that the area under the curve of MHR,FGF21,C-peptide and their combined detection in predicting osteoporosis in T2DM patients was 0.894,0.759,0.810 and 0.969,respectively.Conclusion: The level of MHR in T2DM patients with osteoporosis increases,the levels of FGF21 and C-peptide decrease,and the above indicators are closely related to osteoporosis in T2DM patients.The combined detection of MHR,FGF21 and C-peptide levels has a good application value in predicting osteoporosis in T2DM patients.

参考文献/References:

[1] 冯蓬,陈德强.基于生物信息学探讨骨质疏松症与2型糖尿病的关系[J].中国骨质疏松杂志,2020,26(4):469-473.
[2] 张炳坤,张喜善.骨代谢标志物在骨质疏松症诊治中的应用[J].中国矫形外科杂志,2022,30(16):1483-1486.
[3] 师毓惠,敬泽慧,杨发满.中老年男性T2DM患者血清中RBP4、BMP2水平变化与骨质疏松的关系[J].中国老年学杂志,2022,42(12):2890-2892.
[4] HOFBAUER L C,BUSSE B,EASTELL R,et al.Bone fragility in diabetes:Novel concepts and clinical implications[J].Lancet Diabetes Endocrinol,2022,10(3):207-220.
[5] 庄新华,潘丹英,顾春妹.MHR、LPR-5和SOST对2型糖尿病骨质疏松患者发生骨折的预测价值[J].检验医学与临床,2023,20(9):1244-1248,1254.
[6] 邬浩,于继泽,包幸福,等.成纤维细胞生长因子21在骨代谢中作用的研究进展[J].中华医学杂志,2019,99(36):2874-2877.
[7] 马玉海,陈长松,赵健乐.2型糖尿病患者血清FGF21、骨连结蛋白和骨转换指标的相关性研究[J].中国骨质疏松杂志,2020,26(5):671-675.
[8] 肖婷,邓向群.C肽对2型糖尿病性骨质疏松大鼠骨组织代谢及成骨能力的影响[J].中国医院用药评价与分析,2020,20(8):920-924.
[9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
[10] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-443.
[11] ALSHOMAR A,ABDULMONEM W A,AHMAD Q S,et al.Assessment of osteoporosis in patients with type 2 diabetes mellitus:A study from the central region of Saudi Arabia[J].Saudi Med J,2023,44(7):711-716.
[12] 史凡凡,赵继荣,马同,等.中医药治疗糖尿病性骨质疏松症从“脾肾论治”机制[J].陕西中医,2022,43(5):604-607.
[13] 王力平,连天星,胡永荣,等.胸部CT椎体HU值在2型糖尿病骨质疏松症机会性筛查中的价值[J].中国组织工程研究,2024,28(6):950-954.
[14] 李硕,倪向敏,王建.2型糖尿病性骨质疏松症发病机制研究进展[J].中国骨质疏松杂志,2021,27(11):1661-1665.
[15] 王荣锋,郁昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,48(8):1032-1034,1041.
[16] 陈宏丹,梁荣珍,林德文,等.老年2型糖尿病患者血清Hb、 NLR与BMD、骨代谢及骨质疏松的相关性[J].中国老年学杂志,2023,43(5):1043-1045.
[17] 邹姝乐,韩孟冉,杜岑,等.2型糖尿病患者体质指数与单核细胞/高密度脂蛋白胆固醇比值相关性的研究[J].中国糖尿病杂志,2022,30(9):652-656.
[18] 倪会芳,李隽,丁源,等.中性粒细胞/淋巴细胞比值和单核细胞/高密度脂蛋白胆固醇比值预测绝经后2型糖尿病患者发生骨质疏松症的价值研究[J].中国全科医学,2022,25(18):2207-2214.
[19] 崔翠,李静,张华北,等.血清单核细胞/高密度脂蛋白胆固醇比值、尿白蛋白/肌酐比值对糖尿病肾病患者发生骨质疏松的评估价值[J].中华内分泌外科杂志,2023,17(2):214-218.
[20] 张瑞,周翔海,蔡晓凌,等.不同病程2型糖尿病患者血清成纤维细胞生长因子21与代谢指标的相关性研究[J].中国糖尿病杂志,2021,29(9):665-668.
[21] 马艳琦,刘露霞,王瑛,等.中老年2型糖尿病患者血清FGF21、FGF23水平与骨量异常关系的研究[J].中国骨质疏松杂志,2022,28(2):157-161.
[22] 张晓奎,裴枫,王新浩.骨质疏松患者Klotho水平变化特点及临床意义研究[J].实验与检验医学,2019,37(3):389-391,394.
[23] 马晓军.外周血C肽、糖化血红蛋白和血糖水平与2型糖尿病患者并发症发生关系及其预测价值研究[J].陕西医学杂志,2023,52(9):1211-1213.
[24] 王敏,耿亚辉.2型糖尿病合并骨质疏松危险因素的研究进展[J].北京医学,2022,44(7):636-639.
[25] 张翠兰,赵汉儒,李玲,等.老年2型糖尿病患者空腹C肽、25-羟基维生素D水平与骨密度的关系研究[J].解放军医药杂志,2022,34(2):83-86.

相似文献/References:

[1]曹振振,韩会会,杨文义.肝癌患者血清成纤维细胞生长因子21和富亮氨酸α2糖蛋白1表达情况及临床意义[J].陕西医学杂志,2023,52(3):305.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.013]
　CAO Zhenzhen,HAN Huihui,YANG Wenyi.Expression of FGF21 and LRG1 in serum of patients with hepatocellular carcinoma and its clinical diagnostic value[J].,2023,52(1):305.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.013]

备注/Memo

备注/Memo:
基金项目:四川省卫生健康委员会医学科技项目(21PJ154)
更新日期/Last Update: 2024-01-05